Exisulind
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Exisulind, covering 2009-11-16 to 2018-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer [Phase 2]